dc.contributor.author |
Ursan R. |
|
dc.contributor.author |
Odnoshivkina U. |
|
dc.contributor.author |
Petrov A. |
|
dc.date.accessioned |
2021-02-25T20:35:26Z |
|
dc.date.available |
2021-02-25T20:35:26Z |
|
dc.date.issued |
2020 |
|
dc.identifier.issn |
0898-6568 |
|
dc.identifier.uri |
https://dspace.kpfu.ru/xmlui/handle/net/161897 |
|
dc.description.abstract |
© 2019 Elsevier Inc. Oxidation of membrane cholesterol is a hallmark of many pathological conditions, including cardiovascular diseases. Cholesterol could be oxidized in a result of free radical and enzymatic reactions. Here, we studied the effect of cholesterol oxidation by cholesterol oxidase (ChO) on responses to β-AR stimulation in isolated mouse atria. Acute exposure to ChO led to partial cholesterol oxidation without a significant change in atrial membrane cholesterol content. Pretreatment with ChO itself did not affect contractions and Ca2+ transient amplitude. However, cholesterol oxidation markedly suppressed β-AR-mediated increase in contractility and Ca2+ transient as well as NO levels. At the same time, ChO markedly facilitated β-AR-induced reactive oxygen species (ROS) production. Antioxidant and protein kinase C inhibitor prevented the depressant action of ChO on ISO-dependent contractility, Ca2+ transient and NO production. Similar effects had a selective β2-AR antagonist, which also suppressed the increase in ROS levels after ChO pretreatment. These results suggest that membrane cholesterol oxidation enhances β2-AR-dependent elevation of ROS production, leading to suppression of β-AR-mediated increase in contractility, Ca2+ transient and NO synthesis in mice atria. The oxidative cholesterol modification could contribute to disturbance in β-AR signaling in pathological conditions. |
|
dc.relation.ispartofseries |
Cellular Signalling |
|
dc.subject |
Cholesterol |
|
dc.subject |
Heart |
|
dc.subject |
Nitric oxide |
|
dc.subject |
Oxysterols |
|
dc.subject |
Reactive oxygen species |
|
dc.subject |
β-Adrenoceptors |
|
dc.title |
Membrane cholesterol oxidation downregulates atrial β-adrenergic responses in ROS-dependent manner |
|
dc.type |
Article |
|
dc.relation.ispartofseries-volume |
67 |
|
dc.collection |
Публикации сотрудников КФУ |
|
dc.source.id |
SCOPUS08986568-2020-67-SID85076629691 |
|